Fuss Brands Corp. (FBDS)
| Market Cap | 1.72M +60.0% |
| Revenue (ttm) | n/a |
| Net Income | -149.44K |
| EPS | -0.01 |
| Shares Out | 21.45M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,790 |
| Open | 0.0800 |
| Previous Close | n/a |
| Day's Range | 0.0800 - 0.0800 |
| 52-Week Range | 0.0100 - 0.5500 |
| Beta | -2.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 10, 2026 |
About Fuss Brands
Fuss Brands Corp. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as China Botanic Pharmaceutical Inc. and changed its name to Fuss Brands Corp. in July 2022. Fuss Brands Corp. was incorporated in 1988 and is based in New York, New York. [Read more]
Financial Performance
Financial StatementsNews
Fuss Brands Corp. Announces Manufacturing and Sales Agreements, No Longer Defined as a Shell Company
NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- Fuss Brands Corp. (OTC: FBDS), a leading provider of innovative products to the general public, is pleased to announce that it has recently signed a manufa...
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Fuss Brands Corp. (OTC Markets: FBDS) announced today the signing of an exclusive and irrevocable worldwide license with Anyvention Ltd. that grants Fuss Br...